State Of Wyoming Biocryst Pharmaceuticals Inc Transaction History

State Of Wyoming

$676 Million
Q3 2024

A detailed history of State Of Wyoming transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, State Of Wyoming holds 52,517 shares of BCRX stock, worth $399,129. This represents 0.06% of its overall portfolio holdings.

Number of Shares

52,517

Previous 6,835 668.35%

Holding current value

$399,129

Previous $42,000 850.0%

% of portfolio

0.06%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$6.41 - $8.69 $292,821 - $396,976	45,682 Added 668.35%	52,517 $399,000
Q2 2024 Aug 14, 2024	SELL	$4.13 - $6.79 $16,862 - $27,723	-4,083 Reduced 37.4%	6,835 $42,000
Q1 2024 May 13, 2024	BUY	$4.89 - $7.65 $34,616 - $54,154	7,079 Added 184.4%	10,918 $55,000
Q4 2023 Feb 14, 2024	BUY	$4.98 - $6.77 $2,395 - $3,256	481 Added 14.32%	3,839 $22,000
Q3 2023 Nov 14, 2023	BUY	$6.71 - $7.92 $7,568 - $8,933	1,128 Added 50.58%	3,358 $23,000
Q2 2023 Aug 14, 2023	BUY	$6.96 - $8.81 $6,876 - $8,704	988 Added 79.55%	2,230 $15,000
Q1 2023 May 12, 2023	SELL	$7.94 - $11.84 $14,204 - $21,181	-1,789 Reduced 59.02%	1,242 $10,000
Q4 2022 Feb 14, 2023	BUY	$10.5 - $14.2 $31,825 - $43,040	3,031 New	3,031 $34,000
Q2 2022 Aug 15, 2022	BUY	$7.89 - $17.88 $2,059 - $4,666	261 Added 31.79%	1,082 $11,000
Q1 2022 May 13, 2022	BUY	$11.56 - $19.76 $1,595 - $2,726	138 Added 20.2%	821 $13,000
Q4 2021 Feb 11, 2022	SELL	$11.18 - $15.46 $413 - $572	-37 Reduced 5.14%	683 $9,000
Q3 2021 Feb 11, 2022	SELL	$14.21 - $17.65 $4,916 - $6,106	-346 Reduced 32.46%	720 $10,000
Q2 2021 Feb 11, 2022	BUY	$9.5 - $17.24 $5,367 - $9,740	565 Added 112.77%	1,066 $17,000
Q1 2021 Feb 08, 2022	BUY	$7.37 - $13.61 $3,692 - $6,818	501 New	501 $5,000

Others Institutions Holding BCRX

# of Institutions

279

Shares Held

172M

Call Options Held

625K

Put Options Held

739K

View Full List

About BIOCRYST PHARMACEUTICALS INC

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.41B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

More about BCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wyoming with notifications on news.

Account